Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7518)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ozer Etik D, Ocal S, Boyacioglu AS. Hepatitis C infection in hemodialysis patients: A review. World J Hepatol 2015; 7(6): 885-895 [PMID: 25937865 DOI: 10.4254/wjh.v7.i6.885] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i6/885.htm |
| Number | Citing Articles |
| 1 |
Reza Naghdi, Mitra Ranjbar, Farah Bokharaei-Salim, Hossein Keyvani, Shokoufeh Savaj, Shahrzad Ossareh, Amir Shirali, Amir H. Mohammad-Alizadeh. Occult Hepatitis C Infection Among Hemodialysis Patients: A Prevalence Study. Annals of Hepatology 2017; 16(4): 510 doi: 10.5604/01.3001.0010.0277
|
| 2 |
T Olea, I Castillo, C Jiménez, J Díez, J Bartolomé, MJ Santana, MO López- Oliva, E González, R Selgas, V Carreño. Epidemiological and clinical implications in Kidney Transplantation of occult Hepatitis C virus infection. Archives of Clinical Nephrology 2019; 5(1): 009 doi: 10.17352/acn.000036
|
| 3 |
Rashmi K S, Faiza Samreen, Anjana Gopi, Swati Jain. SEROPREVALENCE OF HCV INFECTION AMONG PATIENTS IN A TERTIARY CARE HOSPITAL IN BANGALORE. Journal of Evolution of Medical and Dental Sciences 2017; 6(31): 2541 doi: 10.14260/Jemds/2017/550
|
| 4 |
Yasser B.M. Ali, Saad G. Moussa, Samar M. Shahen, Mohammed A. Dewir, Ibrahim H. El-Sayed. Association between interleukin-6 gene polymorphism and iron regulation in hemodialysis patients infected with HCV. Brazilian Journal of Nephrology 2020; 42(4): 437 doi: 10.1590/2175-8239-jbn-2019-0188
|
| 5 |
Ruzica Lukic, Nevena Gajovic, Ivan Jovanovic, Milena Jurisevic, Zeljko Mijailovic, Veljko Maric, Biljana Popovska Jovicic, Nebojsa Arsenijevic. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/6275987
|
| 6 |
Jessica I Bravo Zuñiga, César Loza Munárriz, Jesús López-Alcalde. Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units. Cochrane Database of Systematic Reviews 2016; 2016(8) doi: 10.1002/14651858.CD006420.pub2
|
| 7 |
Ali Nada, Mohamed Abbasy, Aliaa Sabry, Azza Mohamed Abdu Allah, Somaia Shehab-Eldeen, Nada Elnaidany, Hanan Elimam, Kawthar Ibraheem Mohamed Ibraheem, Abdallah Essa. Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/1632959
|
| 8 |
Nikolaos Papadopoulos, Ioannis Griveas, Eirini Sveroni, Vasiliki Argiana, Antonios Kalliaropoulos, Beatriz Martinez-Gonzalez, Melanie Deutsch. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?. The International Journal of Artificial Organs 2018; 41(3): 168 doi: 10.1177/0391398817752326
|
| 9 |
Ramit Mahajan, Vandana Midha, Omesh Goyal, Varun Mehta, Vikram Narang, Kirandeep Kaur, Arshdeep Singh, Dharmatma Singh, Rishu Bhanot, Ajit Sood. Clinical profile of hepatitis C virus infection in a developing country: India. Journal of Gastroenterology and Hepatology 2018; 33(4): 926 doi: 10.1111/jgh.13995
|
| 10 |
Eva Schrezenmeier, Friederike Hoffmann, Carsten Jaeger, Jens Schrezenmeier, Jan Lisec, Petra Glander, Engi Algharably, Reinhold Kreutz, Klemens Budde, Michael Duerr, Fabian Halleck. Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus–Positive Kidney Transplant Recipients. Therapeutic Drug Monitoring 2019; 41(1): 53 doi: 10.1097/FTD.0000000000000567
|
| 11 |
Yash Mittal, AnnMarie Liapakis, Joseph K. Lim. Treatment of chronic hepatitis C virus infection in patients with end‐stage renal disease on hemodialysis. Clinical Liver Disease 2016; 8(3): 76 doi: 10.1002/cld.575
|
| 12 |
Faisal Abaalkhail, Waleed Al-hamoudi, Ibrahim Altraif, Hazem Mohamed, Hassan Aleid, Dieter Broering, Saleh Alqahtani. Treatment with Grazoprevir/Elbasvir in Post-kidney Transplant Patients with Hepatitis C Virus Genotype 4 Infection. Hepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.110260
|
| 13 |
Rafat Zreiq, Fahad Dhafer Algahtani, Reem Mustafa Ali, Mohammad Al-Najjar, Shadi Suleiman, Fares Alshammari, Ehab Badran Rakha, Thekra Hamoud Alshammari. Frequency of Hepatitis C Infection in Hospital Patients in Ha'il, KSA: A Retrospective Analysis. International Journal Of Pharmaceutical Research And Allied Sciences 2022; 11(3): 11 doi: 10.51847/4ONr2NFeRo
|
| 14 |
Jakapat Vanichanan, Suwasin Udomkarnjananun, Yingyos Avihingsanon, Kamonwan Jutivorakool. Common viral infections in kidney transplant recipients. Kidney Research and Clinical Practice 2018; 37(4): 323 doi: 10.23876/j.krcp.18.0063
|
| 15 |
M. S. Moore, A. Bocour, A. Winters. Dialysis facility screening and testing practices in the era of improved hepatitis C treatment. Journal of Viral Hepatitis 2018; 25(9): 1099 doi: 10.1111/jvh.12907
|
| 16 |
Sumit Rungta, Shweta Kumar, Sukanya Tripathy, Sant Pandey, Kamlendra Verma, Ghulam Akhtar, Suchit Swaroop, Amar Deep. Prevalence of Hepatitis B and Hepatitis C Virus Infection in Patients with Advanced Renal Failure: A Tertiary Care Centre Study from North Indian Population. Indian Journal of Community Health 2022; 34(4): 464 doi: 10.47203/IJCH.2022.v34i04.003
|
| 17 |
Alessio Strazzulla, Giuseppe Coppolino, Concetta Di Fatta, Francesca Giancotti, Giuseppina D’Onofrio, Maria Concetta Postorino, Maria Mazzitelli, Selma Valerie Mammone, Innocenza Gentile, Laura Rivoli, Eleonora Palella, Tiziana Gravina, Chiara Costa, Vincenzo Pisani, Vincenzo De Maria, Giorgio Settimo Barreca, Nadia Marascio, Alfredo Focà, Giorgio Fuiano, Elio Gulletta, Carlo Torti. Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?. World Journal of Hepatology 2016; 8(19): 815-824 doi: 10.4254/wjh.v8.i19.815
|
| 18 |
Lucy Somerville, Karen Doucette. Hepatitis C: Current Controversies and Future Potential in Solid Organ Transplantation. Current Infectious Disease Reports 2018; 20(7) doi: 10.1007/s11908-018-0625-x
|
| 19 |
Amit Goel, Dharmendra Singh Bhadauria, Anupma Kaul, Narayan Prasad, Amit Gupta, Raj Kumar Sharma, Praveer Rai, Rakesh Aggarwal. Safety and effectiveness of response‐guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis. Nephrology 2017; 22(9): 706 doi: 10.1111/nep.12833
|
| 20 |
Tiffany Wong, Roy D. Bloom. Management and treatment of the HCV‐infected kidney transplant patient. Seminars in Dialysis 2019; 32(2): 169 doi: 10.1111/sdi.12766
|
| 21 |
Mostafa Abdelsalam, Mona M. Tawfik, Alaa Habib, Ahmed Abdel-Razik, Nahla Anber, Maysaa Zaki, Mohammad S. Marie. Occult hepatitis C virus infection among Egyptian hemodialysis patients and its potential effect on anemia management. The Egyptian Journal of Internal Medicine 2019; 31(4): 783 doi: 10.4103/ejim.ejim_94_19
|
| 22 |
C. Rajasekaran, D. Kalpanaraj, S. Thasneem Banu, M. Duraivel. Seroprevalence of Hepatitis C Virus Infection among Hemodialysis Patients in A Tertiary Care Hospital in South India. Journal of Pure and Applied Microbiology 2023; 17(1): 371 doi: 10.22207/JPAM.17.1.27
|
| 23 |
Shahab Mahmoudvand, Somayeh Shokri, Azarakhsh Azaran, Seyed S. Seyedian, Manoochehr Makvandi, Habibollah Mirzaei, Sheida B. Sheikhrobat. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study. Therapeutic Apheresis and Dialysis 2021; 25(2): 218 doi: 10.1111/1744-9987.13535
|
| 24 |
Radomir Reszke, Jacek C. Szepietowski. End-Stage Renal Disease Chronic Itch and Its Management. Dermatologic Clinics 2018; 36(3): 277 doi: 10.1016/j.det.2018.02.007
|
| 25 |
Mahmood Abdujabar Altobje, Zeyad Thanoon Al-Rrassam. The Estimate of Interferon-inducible Protein-10 and Interferon-γ in Hemodialysis Patients with Chronic HCV. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 928 doi: 10.3889/oamjms.2021.7030
|
| 26 |
Yasamen Raad Humudat. Assessment of the impact of anemia on hematological parameters among hemodialysis patients with chronic kidney disease. Bionatura 2023; 8(1): 1 doi: 10.21931/RB/2023.08.01.32
|
| 27 |
Sara Belga, Karen Elizabeth Doucette. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World Journal of Gastroenterology 2016; 22(4): 1650-1663 doi: 10.3748/wjg.v22.i4.1650
|
| 28 |
|
| 29 |
Mahmoud M. Elnokeety, Rasha Ahmed Darwish, Mohamed Tharwat Hegazy, Sameh Abouzeid, Ahmed Fayed. The impact of HCV eradication using interferon-free direct acting antivirals on bone-mineral, anemia parameters and peripheral insulin resistance in hepatitis c-infected Egyptian hemodialysis cohort. Renal Replacement Therapy 2023; 9(1) doi: 10.1186/s41100-023-00500-4
|
| 30 |
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Shuichi Matsumoto, Takayasu Ohtake, Takeshi Kinbara, Machiko Oka, Yasuhiro Yamanouchi, Takehiko Kunieda, Hiroki Yamanoue, Takayuki Kanemaru, Kazuhiko Tsutsumi, Tomoaki Fujikawa, Ji Hyun Sung, Makoto Kako. Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter study. Renal Replacement Therapy 2017; 3(1) doi: 10.1186/s41100-016-0091-6
|
| 31 |
Primploy Greeviroj, Tanat Lertussavavivat, Thana Thongsricome, Kullaya Takkavatakarn, Jeerath Phannajit, Yingyos Avihingsanon, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Paweena Susantitaphong. The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis. Journal of Nephrology 2022; 35(9): 2269 doi: 10.1007/s40620-022-01483-x
|
| 32 |
Parmvir Parmar, Curtis Cooper. Management of hepatitis C in a patient undergoing solid organ (kidney) transplant. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2018; 3(4): 231 doi: 10.3138/jammi.2017-0009
|
| 33 |
|
| 34 |
Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, Hidenori Toyoda, Toshifumi Tada, Koichi Takaguchi, Kunihiko Tsuji, Ei Itobayashi, Daichi Takizawa, Masashi Hirooka, Yohei Koizumi, Hironori Ochi, Koji Joko, Yoshiyasu Kisaka, Yuko Shimizu, Kazuto Tajiri, Joji Tani, Tatsuya Taniguchi, Akiko Toshimori, Shinichi Fujioka. Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation. Molecular and Clinical Oncology 2017; 6(4): 455 doi: 10.3892/mco.2017.1192
|
| 35 |
Yasser B. M. Ali, Saad G. Moussa, Mohammed A. Dewir, Ibrahim H. El-Sayed. Evaluation of hepcidin level in chronic hepatitis C Egyptian patients undergoing regular hemodialysis. The Journal of Basic and Applied Zoology 2018; 79(1) doi: 10.1186/s41936-018-0040-8
|
| 36 |
Hend Naguib, Shady Fouad Abouelnaga, Mohamed Mamdouh Elsayed. Occult hepatitis C virus infection in hemodialysis patients who achieved a sustained virological response to directly acting antiviral drugs: is it a concern?. International Urology and Nephrology 2023; 56(1): 217 doi: 10.1007/s11255-023-03621-1
|
| 37 |
Maya I. Davis, Donald F. Chute, Raymond T. Chung, Meghan E. Sise. When and how can nephrologists treat hepatitis C virus infection in dialysis patients?. Seminars in Dialysis 2018; 31(1): 26 doi: 10.1111/sdi.12650
|
| 38 |
Minh Cuong Duong, Mary‐Louise McLaws. Screening haemodialysis patients for hepatitis C in Vietnam: The inconsistency between common hepatitis C virus serological and virological tests. Journal of Viral Hepatitis 2019; 26(1): 25 doi: 10.1111/jvh.12994
|
| 39 |
Helen Te, Karen Doucette. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clinical Transplantation 2019; 33(9) doi: 10.1111/ctr.13514
|
| 40 |
Yoshiaki Tanaka, Takanori Masaki, Haruki Uojima, Takayasu Ohtake, Tomoaki Fujikawa, Yasuhiro Yamanouchi, Naohisa Wada, Kousuke Kubota, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Togo Aoyama, Ji Hyun Sung, Makoto Kako, Shuzo Kobayashi, Yasuo Takeuchi, Wasaburo Koizumi. Glecaprevir and pibrentasvir combination therapy for hepatitis C virus-infected Japanese patients on hemodialysis. Renal Replacement Therapy 2018; 4(1) doi: 10.1186/s41100-018-0193-4
|
| 41 |
Engy A. Mogahed, Hanan Abdelaziz, Heba Helmy, Haytham Ghita, Mohamed A. Abdel Mawla, Fetouh Hassanin, Fatina I. Fadel, Hanaa El-Karaksy. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis. Journal of Interferon & Cytokine Research 2016; 36(12): 681 doi: 10.1089/jir.2016.0019
|